DMC Biotechnologies, Inc. — Form D/A
DMC Biotechnologies, Inc. of BOULDER, CO, a company, filed a Form D amendment with the SEC on 2019-03-15. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-03-15
- Form: D/A
- Accession: 0001728411-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $2.5M
- Investors: 3
- Date of first sale: 2018-01-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-303493
Issuer
- Name: DMC Biotechnologies, Inc.
- CIK: 0001728411
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 2477 55TH STREET, SUITE 120, BOULDER, CO, 80301
- Phone: 720-239-7239
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Matthew L Lipscomb | Director | Boulder, CO |
| Matthew L Lipscomb | Executive Officer | Boulder, CO |
| Josh Yelen | Executive Officer | Boulder, CO |
| Josko Bobanovic | Director | Boulder, CO |
| Rob van der Meij | Director | Boulder, CO |
| K'Lynne Johnson | Director | WOODRIDGE, IL |
| Alastair Cooper | Director | Boulder, CO |
| Jim Flatt | Director | Boulder, CO |
| Jim Flatt | Executive Officer | Boulder, CO |
| Doug Cameron | Director | Boulder, CO |
| Matthew Lipscomb | Director | Boulder, CO |
| Matthew Lipscomb | Executive Officer | Boulder, CO |
| Michael D Lynch | Director | Salisbury, CT |
| Doug D Cameron | Director | Boulder, CO |
| Carolyn D Fritz | Director | Boulder, CO |
| Rob D van der Meij | Director | Boulder, CO |
| Ashley D Jenkins | Executive Officer | Boulder, CO |
| Alastair D Cooper | Director | Boulder, CO |
| Josko D Bobanovic | Director | Niwot, CO |
Other filings by this issuer (8)
More